Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2116035 | Cancer Letters | 2006 | 10 Pages |
Abstract
α-Tocopheryl succinate (α-TOS) exerts pleiotrophic responses in malignant cells leading to cell cycle arrest, differentiation and apoptosis. We tested the ability of α-TOS to induce apoptosis or cell cycle perturbation in three human osteosarcoma (OS) cell lines which differ in their pRB and p53 status. We found high levels of apoptosis in OS cells carrying wild-type p53 gene when exposed to α-TOS, while the mutant p53 cells were resistant. A S/G2 transition arrest was observed in two OS cell lines exposed to α-TOS, which sensitised them to methotrexate, an agent whose activity is cell cycle-dependent. We propose that α-TOS may be used as a drug or an adjuvant for treatment of osteosarcomas.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Renata Alleva, Maria Serena Benassi, Laura Pazzaglia, Marco Tomasetti, Nina Gellert, Battista Borghi, Jiri Neuzil, Piero Picci,